Posted on 8/2/17
HealthWell Foundation Opens Giant Cell Arteritis Fund
The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has opened a Giant Cell Arteritis Fund to provide copayment and . . .
Posted on 8/2/17
Integrated BioTherapeutics, in Collaboration with The Scripps Research Institute, Receives NIH Funding
Integrated BioTherapeutics Inc. (IBT) announced today that it has been awarded a $6.6 million grant by the National Institute of Allergy and Infectious Diseases (NIAID) to . . .
Posted on 8/1/17
Biotechnology Company Aperiomics Launches New Website
Aperiomics, a biotechnology company that saves lives by harnessing next-generation sequencing to identify any known pathogen (bacteria, virus, fungi or parasite) in a single test to . . .
Posted on 8/1/17
Collection Time: Medical School Debt Now Officially Martinsville's Responsibility
Dr. Noel Boaz and his company, the Integrative Centers for Science and Medicine, can’t afford to repay the grant given for their proposed medical school. That . . .
Posted on 8/1/17
Emergent BioSolutions Awarded $23 Million
GAITHERSBURG, Md., July 31, 2017 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded approximately $23 million to develop a novel . . .
Posted on 7/28/17
DC's Top GI Practice Taps Two Physicians for Rockville Location
Capital Digestive Care has tapped two new physicians for its growing Rockville office on 14955 Shady Grove Road. Both doctors are highly-trained medical professionals who are . . .
Posted on 7/28/17
Skanska and Perkins+Will Help to Raise More than $20,000 for Virginia Institute of Autism
Second Annual Golf Tournament Supports Education, Outreach and Adult Services Programs for People with Autism in Central VirginiaThe second annual Virginia Institute of Autism (VIA) Golf . . .
Posted on 7/28/17
Novavax, Inc.: Buy the Dip?
Novavax's (NASDAQ:NVAX) investors can't seem to catch a break. The clinical-stage vaccine maker has been down on its luck ever since it released disappointing phase 3 . . .
Posted on 7/27/17
Neuralstem Prices Public Offering of Common Stock and Warrants
GERMANTOWN, Md., July 27, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced the pricing of . . .
Posted on 7/27/17
United Therapeutics Reports Q2 2017 Financial Results
United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2017."Our second quarter total net revenues reached $445 million, . . .
Posted on 7/26/17
Immunomic Therapeutics and BioBuzz Maryland to Celebrate Advancement of the Investigational LAMP-Vax Technology
ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI) announced today that they will celebrate the company’s recent pivot to oncology application with their investigational LAMP-Vax™technology tomorrow. The event . . .
Posted on 7/26/17
Why Novavax, Inc Is Tanking Today
What happenedAfter providing investors with a number of clinical updates, Novavax (NASDAQ:NVAX), a clinical-stage biotech focused on vaccines, saw its shares decline 24% as of 11:45 . . .
Posted on 7/25/17
Vixiar Medical Raises $1.5 Million in Seed Round Financing
Vixiar Medical, Inc., a privately held Maryland company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases
Posted on 7/25/17
Why Novavax Stock Spiked Today
What happenedShares of the clinical-stage vaccine-maker Novavax (NASDAQ:NVAX) gained as much as 18.2% today on sky-high volume. This noteworthy uptick was sparked by the anticipation surrounding . . .
Posted on 7/25/17
4D Molecular Therapeutics and Foundation Fighting Blindness Partner
EMERYVILLE, Calif. & COLUMBIA, Md.--(BUSINESS WIRE)--4D Molecular Therapeutics (4DMT), a leader in adeno-associated virus (AAV) gene therapy vector discovery and product development, and the Foundation Fighting . . .
Posted on 7/24/17
Should Investors Brace for Bad News From Novavax's Looming Clinical Update?
One press release last week caused shares of clinical-stage biotech Novavax (NASDAQ:NVAX)to soar nearly 25%. The company didn't announce an FDA approval. It didn't even report . . .
Posted on 7/23/17
United Therapeutics Losing The Crown Jewels; 20% EPS Downgrades Ahead
Under the leadership of the American lawyer, author and serial entrepreneur Martine Rothblatt, and driven by a growing PAH franchise, United Therapeutics (NASDAQ:UTHR) has enjoyed revenue . . .
Posted on 7/20/17
Lentigen Technology Acquires Living Pharma
Lentigen Technology Inc., a subsidiary of Miltenyi Biotec GmbH, announced today its acquisition of immunotherapy start-up Living Pharm
Posted on 7/20/17
Emergent BioSolutions To Acquire Raxibacumab From GSK
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an agreement with GSK (LSE/NYSE: GSK)
Posted on 7/20/17
ABL Awarded NIH Contract for HIV Vaccine Development
ROCKVILLE, Md.--(BUSINESS WIRE)--ABL, Inc. (ABL), a global contract research and manufacturing service provider, announced today it has been awarded the recompetition of the contract for “Preclinical . . .
Posted on 7/20/17
MedStar Health and 1776 Announce Startup Pitch Challenge Winners
MedStar Health and 1776 are officially announcing the five winners and one startup designated for “honorable innovation” identified during the #Patient2Consumer startup challenge event on July . . .
Posted on 7/19/17
OpGen Closes $10 Million Public Offering
GAITHERSBURG, Md., July 19, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) announces the closing of its previously announced public offering of 18,164,195 units at $0.40 per . . .
Posted on 7/24/17
FDA Approves Vosevi for Hepatitis C
The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with . . .
Posted on 7/17/17
Noble Life Sciences Granted Renewal of Full AAALAC Accreditation Status
Noble Life Sciences, a contract research organization (CRO) providing services to support the development of drugs, vaccines, and medical devices, is pleased to announce that it . . .
Posted on 7/14/17
Emergent BioSolutions To Acquire ACAM2000 Business From Sanofi For $125M
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an agreement to acquire the ACAM2000
Washington DC
